88 related articles for article (PubMed ID: 17436599)
41. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
42. Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.
Featherstone JM; Lwaleed BA; Speers AG; Hayes MC; Birch BR; Cooper AJ
Urology; 2009 Aug; 74(2):378-84. PubMed ID: 19501884
[TBL] [Abstract][Full Text] [Related]
43. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
44. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of curcumin mimics with multidrug resistance reversal activities.
Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
[TBL] [Abstract][Full Text] [Related]
46. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
47. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
48. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
Yu ST; Chen TM; Tseng SY; Chen YH
Biochem Biophys Res Commun; 2007 Jun; 358(1):79-84. PubMed ID: 17482571
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and conformational analysis of His-Phe-Arg-Trp-NH2 and analogues with antifungal properties.
Masman MF; Rodríguez AM; Svetaz L; Zacchino SA; Somlai C; Csizmadia IG; Penke B; Enriz RD
Bioorg Med Chem; 2006 Nov; 14(22):7604-14. PubMed ID: 16926096
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
[TBL] [Abstract][Full Text] [Related]
51. [Spatial structure of isoleucine pentapeptides Glu-Phe-Leu-Arg-Ile-NH2 and Pro-Phe-Tyr-Arg-Ile-NH2].
Ismailova LI; Akhmedov NA; Abbasly RM
Biofizika; 2008; 53(1):14-21. PubMed ID: 18488495
[TBL] [Abstract][Full Text] [Related]
52. Structure-activity relationships for the cardiotropic action of the Led-NPF-I peptide in the beetles Tenebrio molitor and Zophobas atratus.
Marciniak P; Grodecki S; Konopińska D; Rosiński G
J Pept Sci; 2008 Mar; 14(3):329-34. PubMed ID: 17929328
[TBL] [Abstract][Full Text] [Related]
53. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
54. Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro.
Xie SQ; Hu GQ; Zhang ZQ; Xu M; Ji BS
J Pharm Pharmacol; 2008 Feb; 60(2):213-9. PubMed ID: 18237469
[TBL] [Abstract][Full Text] [Related]
55. Dihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDR.
Miri R; Mehdipour A
Bioorg Med Chem; 2008 Sep; 16(18):8329-34. PubMed ID: 18701304
[TBL] [Abstract][Full Text] [Related]
56. Bombesin-modified 6-14 C-terminal fragments adsorption on silver surfaces: influence of a surface substrate.
Podstawka E; Ozaki Y
Biopolymers; 2008 Nov; 89(11):941-50. PubMed ID: 18615492
[TBL] [Abstract][Full Text] [Related]
57. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
58. Qualitative and quantitative aspects of the degradation of several tripeptides derived from the antitumour peptide antagonist [Arg(6), D-Trp(7,9), MePhe(8)] substance P[6-11].
Reubsaet JL; Beijnen JH; Belshof EH; Bouyakhrichan M; Bult A; Hop E; Kellekule Y; van Maanen RJ; Teeuwsen J; Underberg WJ
J Pharm Biomed Anal; 1999 Mar; 19(3-4):277-84. PubMed ID: 10704092
[TBL] [Abstract][Full Text] [Related]
59. The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice.
Lee DW; Leinung MC; Grasso P
Regul Pept; 2008 Oct; 150(1-3):62-5. PubMed ID: 18455249
[TBL] [Abstract][Full Text] [Related]
60. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
